Rare diseases
Investigational molecules
Locations
A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
AustriaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
AustriaStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
AustriaStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
AustriaStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
AustriaStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen
AustriaMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
AustriaA Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
AustriaEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
AustriaStudy of dapirolizumab pegol placental transfer to infants in pregnant women with active systemic lupus erythematosus (drug combination)
AustriaEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
